Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2010
05/26/2010CN101711762A Medicine composition for treating hypertension
05/26/2010CN101711760A Thiophene derivative with excellent function of blood glucose reduction and adduct PPAR alpha/gamma double agonists thereof
05/26/2010CN101711758A Application of apigenin in preparing medicament for preventing and treating diseases caused by ischemic injuries of humans
05/26/2010CN101711747A Medicine application preparation for treating hypertension
05/26/2010CN101190007B Nutrition food containing bran
05/26/2010CN101161241B Technique of preparing amlodipine besylate tablets
05/26/2010CN101125159B Medicine for treating hemorrhoid, anal fissure and anal fistula
05/26/2010CN101099762B Blood pressue lowering sustained-release preparation with chrysanthemum flower and pearl
05/26/2010CN101066258B Inclusion compound of higher fatty alcohol and its preparation
05/26/2010CN101062114B Method for distilling flavone from tartary buckwheat bran
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
05/26/2010CN101045134B Method for preparing medicine to treat atherosclerosis
05/26/2010CN101040860B Pharmaceutical composition for treatment of lower urinary tract diseases
05/26/2010CN101032505B Treatment medicine and healthy product including liquiritin
05/26/2010CN101032504B Application of liquiritin in medicines
05/26/2010CN100998616B Medicine for treating haemorrhoids and its preapring method
05/25/2010US7724943 Rapid and robust 3D/3D registration technique
05/25/2010US7723505 EAAT2 promoter and uses thereof
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723366 Cardiovascular disorders; antidiabetic agents; anticancer agents
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723342 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
05/25/2010US7723304 Hypotensive agents; cardiovascular disorders; wound healing agents; antitumor agents; antidiabetic agents ; nephropathy; gastrointestinal disorders; alopecia; blood disorders ; urogenital disorders
05/25/2010CA2606843C Improved method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones
05/25/2010CA2584975C Drug and food or drink for improving pancreatic functions
05/25/2010CA2496723C New process for synthesizing ivrabradine and its pharmaceutically acceptable acid addition salts
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2462922C Reverse-turn mimetics and method relating thereto
05/25/2010CA2439295C Carbamate compounds for use in preventing or treating neurodegenerative disorders
05/25/2010CA2431761C Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2375923C Devices and compounds for treating arterial restenosis
05/25/2010CA2369232C Fused pyrazolyl compounds
05/25/2010CA2362273C Benzazepine-n-ethanoic acid derivatives for treating secondary hypertension
05/25/2010CA2326874C Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
05/25/2010CA2314156C Pyrrole substituted 2-indolinone protein kinase inhibitors
05/20/2010WO2010057118A2 Heterocyclic antagonists of prostaglandin d2 receptors
05/20/2010WO2010057066A1 Pharmacokinetically-based dosing regimens of a thrombin receptor antagonist
05/20/2010WO2010057036A2 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
05/20/2010WO2010057028A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010WO2010056985A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010WO2010056910A2 Methods of treating cardiovascular disorders
05/20/2010WO2010056865A1 Quinoline derivatives as ion channel modulators
05/20/2010WO2010056767A1 Thiochromene derivatives as hip hydroxylase inhibitors
05/20/2010WO2010056630A1 Triazolopyrimidinones and methods of use thereof
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010056527A2 Fused heterocyclic compounds as ion channel modulators
05/20/2010WO2010056041A2 Pharmaceutical composition for treating and preventing heart diseases caused by ischemia or ischemic reperfusion
05/20/2010WO2010055419A2 A method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosclerosis
05/20/2010WO2010055119A2 Pharmaceutical composition comprising pimobendan
05/20/2010WO2010054961A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/20/2010WO2010054531A1 Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease
05/20/2010WO2010054512A1 Two types of crystalline of pinocembrin: α and β, their preparation and their use for manufacture of pharmaceutical compositions
05/20/2010WO2010054507A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
05/20/2010WO2010054438A1 Aryl di-substituted propenone compounds
05/20/2010WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof
05/20/2010WO2010014933A3 Psma-binding agents and uses thereof
05/20/2010WO2009152084A3 Adipose tissue-derived stem cells for veterinary use
05/20/2010US20100125091 Substituted heterocyclic compounds as ion channel modulators
05/20/2010US20100125066 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
05/20/2010US20100125065 Carboline derivatives useful in the inhibition of angiogenesis
05/20/2010US20100125050 Process for the Manufacture of Eptifibatide
05/20/2010US20100124550 Amide inhibitors of renin
05/20/2010US20100124541 Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv
05/20/2010DE102008057364A1 New pyridyl or phenyl ring containing compounds are hypoxia-inducible factor regulation pathway modulators, useful to treat and/or prevent e.g. cancer or tumor diseases, heart attack, arrhythmia, stroke, psoriasis and diabetic retinopathy
05/20/2010DE102008057344A1 Aminoalkyl-substituierte Aryl-Verbindungen und ihre Verwendung Aminoalkyl-substituted aryl compounds, and their use
05/20/2010DE102008057343A1 New phenyl or pyridyl ring containing compounds are hypoxia-inducible factor regulation pathway modulators, useful to treat and/or prevent e.g. cancer or tumor diseases, heart attack, arrhythmia, stroke, psoriasis and diabetic retinopathy
05/20/2010CA2743709A1 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010CA2743661A1 Aryl di-substituted propenone compounds
05/20/2010CA2743639A1 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
05/20/2010CA2743618A1 Two types of crystalline of pinocembrin, their preparation and their use for manufacture of pharmaceutical compositions
05/20/2010CA2743434A1 A method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis
05/20/2010CA2743090A1 Use of extracts from rabbit skin inflamed by vaccinia virus in the manufacture of a medicament for treatment of acute cerebrovascular diseases
05/20/2010CA2743006A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010CA2741018A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
05/19/2010EP2186824A2 Chronic treatment regimen using glucagon-like insulinotropic peptides
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2186800A1 New mandelic acid derivatives and their use as thrombin inhibitors
05/19/2010EP2186792A1 2-(a-hydroxypentyl) benzoate and its preparation and use
05/19/2010EP2186530A1 Promoters exhibiting endothelial cell specificity and methods of using same
05/19/2010EP2186524A1 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/19/2010EP2186513A1 Use of specific cyclolignans
05/19/2010EP2186407A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
05/19/2010EP2185719A2 Anti-rantes antibodies and methods of use thereof
05/19/2010EP2185552A1 Dipeptoid prodrugs and the use thereof
05/19/2010EP2185551A2 Prodrugs of 2-amino-6-( { [2-(4-chlorphenyl)-1,3-thiazol-4-yl] methyl}thio)-4-[4-(2-hy-droxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile
05/19/2010EP2185550A1 Substituted aryloxazoles and the use thereof
05/19/2010EP2185523A2 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
05/19/2010EP2185521A2 Compounds and methods for modulating rho gtpases
05/19/2010EP2185511A2 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
05/19/2010EP2185181A2 Therapeutic uses of gastrin-1 and g-pen-grgdspca
05/19/2010EP2185177A1 Use of c-type natriuretic peptide, alone or incombination with neuropeptide af, as a therapeutic agent
05/19/2010EP2185174A1 Use of trim72 as a target for muscle and heart enhancer
05/19/2010EP2185171A2 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents
05/19/2010EP1856059B1 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
1 ... 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 ... 1595